Table 2.
Method | Detection technique | Invasive/noninvasive | Label | Sample | Biomarker | Concentration range of biomarker | Detection limit/detection range | Response time | Ref. |
---|---|---|---|---|---|---|---|---|---|
Cytopathology | Staining | Invasive | – | Cells | – | – | – | 1 week | 5 |
Biopsy | Cell culture | Invasive | – | Tissue | – | – | – | 2–3 weeks | 4 |
Visualization adjuncts | Staining | Invasive | – | Tissue | – | – | – | 1 week | 4 |
Surface plasmon resonance | Noninvasive | Yes | Saliva | IL‐8 (protein) | 29.8–85.9 × 10−12 m | S:– LDR: 1–195 × 10−12 m SL:– | 13 min | 15 | |
Amperometric | Invasive | Yes | Serum | IL‐6 (protein) | ≤6 pg mL−1 to ≥20 pg mL−1 | S: 19.3 nA mL (pg IL‐6)−1 cm−2 LDR: 0.5–30 pg mL−1 SL:– | – | 16 | |
Biosensor | Differential pulse voltametry | Invasive | Yes | Serum | IL‐6 (protein) | <6 pg mL−1 to >20 pg mL−1 | S:– LDR: 0.002–20 ng mL−1 SL: 1 month | – | 17 |
Chrono‐amperometry | Noninvasive | Yes | Saliva | has‐miR‐200a (mi‐RNA) | – | S:– LDR: 1 am to 10 f m SL:– | – | 14 | |
Cyclic voltametry | Noninvasive | No | Saliva | CYFRA‐21‐1 (protein) | 0–18 ng mL−1 | S: 2.2 mA mL ng−1 LDR: 2–16 ng mL−1 SL: 6 weeks | 20 min | Present work |